The rally “Our right is to live without pain!” for the legalization of medical cannabis was held near the President’s Office in Kyiv, Hromadske reports.

Participants of the rally called on the president, government and parliament to take measures to provide access to medicines based on medical cannabis for seriously ill patients as soon as possible. They also require a report on the Government Drug Policy Strategy implementation failure, namely its component, which provides for the scientific research of cannabinoids.

The co-organizers of the action were the Ukrainian community of people with multiple sclerosis, the all-Ukrainian association of people with drug addiction. They were joined by Athena – Women against cancer, Veterans for medical cannabis, City Initiatives and Social Transformations, Ukrainian Students for Freedom and Green Party.

As reported, in May 2019 a draft law regulating the use of cannabis in medicine and scientific research was registered in the Verkhovna Rada.

Earlier European Parliament urged EU member countries to conduct research on the use of medical cannabis – and to create unified regulations for all member countries. The Parliament’s press service reported that.

It is noted that several European countries allowed the use of certain kinds of cannabis or cannabinoids for medical purpose; some countries still consider opportunities for submitting changes to the legal framework.

However, the rules of use of cannabis strongly differ in various countries. No EU member country allows smoking or growing cannabis at home for medical purposes.

Due to these circumstances, the European Parliament calls for extra research on this topic. The respective resolution was approved on February 13. In it, the Parliament asks to provide a legal definition for medical cannabis so that one can tell the difference from other kinds of its use. Besides, the MEPs admitted that these researches should be funded, and the medical insurance should be covering the drugs based on this particular kind of cannabis.